Primary gastric non-Hodgkin's lymphoma: Clinical features, management, and prognosis of 185 patients with diffuse large B-cell lymphoma

Annals of Oncology

Volumn 10, Issue 12, 1999, Pages 1441-1449

  Ibrahim, E M ^a   Ezzat, A A ^a   Raja, M A ^a   Rahal, M M ^a   Ajarim, D S ^a   Mann, B ^a   Baloush, A ^a   Stuart, R K ^a   Bazarbashi, S N ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

Gastric; Large cell; Non Hodgkin's lymphoma

Indexed keywords

ANTINEOPLASTIC AGENT; CYCLOPHOSPHAMIDE; DOXORUBICIN; MITOXANTRONE; PREDNISONE; VINCRISTINE SULFATE;

ADULT; ARTICLE; B CELL LYMPHOMA; CANCER COMBINATION CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER REGRESSION; CANCER SURGERY; CANCER SURVIVAL; CLINICAL FEATURE; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; PROGNOSIS; STOMACH LYMPHOMA; TREATMENT OUTCOME;

ADULT; COMBINED MODALITY THERAPY; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; L-LACTATE DEHYDROGENASE; LOGISTIC MODELS; LYMPHOMA, B-CELL; LYMPHOMA, LARGE-CELL, DIFFUSE; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM PROTEINS; ODDS RATIO; RETROSPECTIVE STUDIES; STOMACH NEOPLASMS; SURVIVAL ANALYSIS;

EID: 0033376481     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008325823967     Document Type: Article

References (42)

1. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1997; 29: 253-60.
2. Glass AG, Karnell LH, Menck HR. The national cancer data base report on non-Hodgkin's lymphoma. Cancer 1997; 80: 2311-20.
3. Otter RT, Gerritis WBJ, Sandt MM et al. Primary extranodal and nodal non-Hodgkin's lymphoma: A survey of a population-based registry. Eur J Cancer Clin Oncol 1989; 25: 1203-10.
4. D'Amore F, Christensen BE, Brincker HK et al. Clinico-pathological features and prognostic factors in extranodal non-Hodgkin's lymphomas. Eur J Cancer 1991; 27: 1201-8.
5. Ahmad M, Malik IA. Non-Hodgkin's lymphoma in developing countries. In Magrath IT (ed): The Non-Hodgkin's Lymphomas, 2nd edition. London: Arnold 1997; 103-1054.
6. Herrmann R, Panahon AM, Barcos M et al. Gastrointestinal involvement in non-Hodgkin's lymphoma. Cancer 1980; 46: 215-22.
7. D'Amore F, Brincker H, Gronbaek K et al. Non-Hodgkin's lymphoma of the gastrointestinal tract. A population-based analysis of incidence, geographic distribution, clinico-pathologic presentation features and prognosis. J Clin Oncol 1994; 12: 1673-84.
8. Zucca E, Roggero E, Bertoni F, Cavalli F. Primary extranodal non-Hodgkin's lymphomas. Part 1: Gastrointestinal, cutaneous and genitourinary lymphomas. Ann Oncol 1997; 8: 727-37.
9. Isaacson PG. Mucosa-associated lymphoid tissue lymphoma. Semin Hematol 1999; 36: 139-147.
10. Roggero E, Zucca E, Pinotti G et al. Eradication of Heliocobacter pylori infection in primary low-grade gastric lymphoma of mucosa-associated lymphoid tissue. Ann Intern Med 1995; 122: 767-9.
11. Bierman PJ, Armitage JO. Non-Hodgkin's lymphoma. Curr Opin Hematol 1996; 3: 266-72.
12. Isaacson PG, Norton AJ (eds). Extranodal Lymphomas. Edinburgh: Churchill Livingstone 1994; 1-329.
13. Rohatiner A. Report on a workshop convened to discuss the pathological and staging classification of gastrointestinal lymphoma. Ann Oncol 1994; 5: 397-400.
14. Shchepotin IB, Stephen D, Evans RT et al. Primary non-Hodgkin's lymphoma of the stomach: Three radical modality of treatment in 75 patients. Ann Surg Oncol 1966; 3: 277-84.
15. Stephens J, Smith J. Treatment of primary gastric lymphoma and gastric mucosa-associated lymphoid tissue lymphoma. J Am Coll Surg 1998; 187: 312-20.
16. Koch P, Grothaus-Pinke B, Hiddemann W et al. Primary lymphoma of the stomach: Three-year results of a prospective multicenter study. The German Multicenter Study Group. Ann Oncol 1997; 8 (Suppl 1): 85-8.
17. Brands F, Monig SP, Raab M. Treatment and prognosis of gastric lymphoma. Eur J Surg 1997; 163: 803-13.
18. Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's Disease's Staging Classification. Cancer Res 31: 1860-1861, 1971.
19. Cox DR, Snell EJ: Analysis of Binary Data. London: Chapman & Hall 1989.
20. Hosmer DW, Lemeshow S. Goodness-of-fit tests for the multiple logistic regression model. Commun Statist - Part A Theror Meth 1980; A9 (10): 1043-69.
21. Prentice RL. A generalization of the probit and logit methods for dose response curves. Biometrics 1976; 32: 761-867.
22. Kaplan EL, Meier P: Nonparametric estimation from incomplete observations. J Am Statist Ass 53: 457-81, 1958.
23. Mantel N. Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep 50: 163-70, 1966.
24. Cox DR, Oakes D: Regression models and life tables (with discussion). J R Statist Soc B34: 187-220, 1972.
25. Dixon WJ, Brwon MB, Engleman L et al. BMDP Statistical Software. Berkeley: University of California Press 1990.
26. Oken MM, Creech RH, Tormey DC. Toxicity and response criteria of the Eastern Cooperative Oncology Group. Am J Clin Oncol 5: 649-55, 1982.
27. Montalban C, Castrillo JM, Serrano M et al. Gastric B-cell mucosa-associated lymphoid tissue (MALT) lymphoma. Clinicopathological study and evaluation of the prognostic factors in 143 patients. Ann Oncol 1995; 6: 355-62.
28. Ferreri AJ, Cordio S, Paro S et al. Therapeutic management of stage I-II high-grade primary gastric lymphomas. Oncology 1999; 56: 274-82.
29. Lucandri G, Stipa F, Mingazzini PL et al. The role of surgery in the treatment of primary gastric lymphoma. Anticancer Res 1998; 18: 2089-94.
30. Colucci E, Naglieri E, Marzullo F et al. Role of prognostic factors in the therapeutic strategy of primary gastric non-Hodgkin's lymphomas. Clin Ter 1998; 149: 25-30.
31. Rodriguez-Sanjuan JC, Alvarez-Canas C, Casado F et al. Results and prognostic factors in stage I(E)-II(E) primary gastric lymphoma after gastrectomy. J Am College Surg 1999; 188: 296-303.
32. Salvagno L, Soraru M, Busetto M et al. Gastric non-Hodgkin's lymphoma: Analysis of 252 patients from a multicenter study. Tumori 1999; 85: 113-21.
33. Castrillo JM, Montalban C, Abraira V et al. Evaluation of the International Index in the prognosis of high grade gastric malt lymphoma. Leuk Lymph 1996; 24: 159-63.
34. Makela J, Karttunen T, Kiviniemi H, Laitinen S. Clinicopathological features of primary gastric lymphoma. J Surg Oncol 1999; 70: 78-82.
35. Hsi ED, Eisbruch A, Greenson JK et al. Classification of primary gastric lymphomas according to histologic features. Am J Surg Path 1998; 22: 17-27.
36. Lucas PJ, Boot H, Taal BG. Computer-based decision support in the management of primary gastric non-Hodgkin lymphoma. Methods of Information in Medicine 1998; 37: 206-19.
37. Haim N, Leviov M, Ben-Arieh et al. Intermediate and high-grade gastric non-Hosgkin's lymphoma: A prospective study of non-surgical treatment with primary chemotherapy, with or without radiotherapy. Leuk Lymph 1995; 321-6.
38. Takenka T, Maruyma K, Kinoshita T et al. A prospective study and adjuvant chemotherapy for primary gastric lymphoma stage II. Br J Cancer 1997; 76: 1484-8.
39. Verreet PR. MALT-lymphoma surgical therapy. Schweiz Rundsch Med Prax 1996; 85: 1451-4.
40. Coiffier B, Salles G. Does surgery belong to medical history for gastric lymphomas? Ann Oncol 1997; 8: 419-21 (Editorial).
41. Avilés A, Diaz-Maqueo JC, de la Torre A et al. Is surgery necessary in the treatment of primary gastric non-Hodgkin's lymphoma? Leuk Lymph 1991; 5: 365-9.
42. Lybeert ML, De Neve W, Vrints LW et al. Primary gastric non-Hodgkin's lymphoma stage IE and IIE. Eur J Cancer 1996; 32A: 2306-11.